Boosting the commercialisation of biomedical research

Burnet Institute

21 November, 2012

Dr Catherine Nie and Dr Renee Duncan are enrolled in the Molecules to Medicine program.

Two young Burnet scientists have been awarded internships that will give them business skills to help translate their promising discoveries into health therapies.

The Centre for Immunology’s Dr Catherine Nie and Dr Renee Duncan from the Centre for Virology are two of 30 researchers across 12 organisations enrolled in the Molecules to Medicine (M2M) program, funded by the Commonwealth and Victorian Governments.

It will provide them with practical on-the-job training and mentoring in technology transfer, translation and the commercial development of biomedical discoveries.

This is achieved through mentoring from members of the Burnet’s Office for Business Development, Innovation team including Serina Cucuzza, manager of Commercial Development and Industry Engagement.

Dr Duncan said the M2M initiative would improve her ability to collaborate within Burnet and also bridge the gap between medical researchers and Industry.

“The program has had a remarkable impact on my current project, identifying potential new sources of funding and improved awareness of patentable material,” she said.

“I am drawing on these skills and am in the process of putting together a Business Research Plan for a pharmaceutical company to fund a development project surrounding the exploration of novel screening tests and treatments to help overcome HIV drug resistance.”

Dr Nie is working to identify and evaluate technology transfer and translation opportunities within the Malaria Research Laboratory.

“I am also organising and managing material transfer and collaboration agreements,” she said.

“Importantly, this program helps to address the urgent need to better capture health and commercial value from the world-leading research happening at the Institute.”

Contact Details

For more information in relation to this news article, please contact:

Serina Cucuzza

Executive General Manager, Commercial Strategy and Industry Partnerships




Subscribe to News

Subscribe to receive our latest news: